Isofol Medical AB - Asset Resilience Ratio

Latest as of December 2025: 65.69%

Isofol Medical AB (ISOFOL) has an Asset Resilience Ratio of 65.69% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Isofol Medical AB for a breakdown of total debt and financial obligations.

Liquid Assets

Skr85.00 Million

≈ $9.15 Million USD Cash + Short-term Investments

Total Assets

Skr129.40 Million

≈ $13.93 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Isofol Medical AB's Asset Resilience Ratio has changed over time. See ISOFOL book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Isofol Medical AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Isofol Medical AB (ISOFOL) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr85.00 Million	65.69%
Total Liquid Assets	Skr85.00 Million	65.69%

Asset Resilience Insights

Very High Liquidity: Isofol Medical AB maintains exceptional liquid asset reserves at 65.69% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Isofol Medical AB Industry Peers by Asset Resilience Ratio

Compare Isofol Medical AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Isofol Medical AB (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Isofol Medical AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	65.69%	Skr85.00 Million ≈ $9.15 Million	Skr129.40 Million ≈ $13.93 Million	-32.01pp
2024-12-31	97.70%	Skr96.16 Million ≈ $10.35 Million	Skr98.42 Million ≈ $10.59 Million	-0.55pp
2023-12-31	98.26%	Skr138.15 Million ≈ $14.87 Million	Skr140.60 Million ≈ $15.13 Million	+8.98pp
2022-12-31	89.28%	Skr190.58 Million ≈ $20.51 Million	Skr213.46 Million ≈ $22.97 Million	-5.26pp
2021-12-31	94.54%	Skr379.45 Million ≈ $40.83 Million	Skr401.36 Million ≈ $43.19 Million	+15.96pp
2020-12-31	78.57%	Skr116.39 Million ≈ $12.53 Million	Skr148.13 Million ≈ $15.94 Million	-8.12pp
2019-12-31	86.70%	Skr126.98 Million ≈ $13.67 Million	Skr146.47 Million ≈ $15.76 Million	-7.88pp
2018-12-31	94.57%	Skr272.90 Million ≈ $29.37 Million	Skr288.55 Million ≈ $31.05 Million	-4.33pp
2017-12-31	98.91%	Skr357.33 Million ≈ $38.45 Million	Skr361.28 Million ≈ $38.88 Million	+15.40pp
2016-12-31	83.50%	Skr19.11 Million ≈ $2.06 Million	Skr22.89 Million ≈ $2.46 Million	--

pp = percentage points

About Isofol Medical AB

ST:ISOFOL Sweden Biotechnology

Market Cap

$20.39 Million

Skr189.47 Million SEK

Market Cap Rank

#24975 Global

#506 in Sweden

Share Price

Skr0.67

Change (1 day)

+0.60%

52-Week Range

Skr0.58 - Skr1.86

All Time High

Skr33.00